Insufficient scRNA-seq data for expression of RIPK3 at single-cell level.
Insufficient scRNA-seq data for expression of RIPK3 at tissue level.
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
thymus | 100% | 1347.34 | 652 / 653 | 97% | 9.55 | 586 / 605 |
stomach | 99% | 855.65 | 355 / 359 | 97% | 12.89 | 277 / 286 |
pancreas | 99% | 465.04 | 324 / 328 | 97% | 14.79 | 172 / 178 |
intestine | 96% | 1179.84 | 932 / 966 | 99% | 14.73 | 521 / 527 |
lung | 100% | 976.77 | 576 / 578 | 94% | 7.76 | 1083 / 1155 |
bladder | 95% | 620.86 | 20 / 21 | 89% | 9.40 | 450 / 504 |
esophagus | 99% | 660.38 | 1426 / 1445 | 85% | 7.92 | 156 / 183 |
breast | 100% | 1043.26 | 459 / 459 | 80% | 6.92 | 893 / 1118 |
uterus | 95% | 403.94 | 162 / 170 | 80% | 6.93 | 368 / 459 |
skin | 96% | 640.69 | 1730 / 1809 | 48% | 2.30 | 228 / 472 |
kidney | 90% | 416.21 | 80 / 89 | 49% | 1.91 | 443 / 901 |
prostate | 95% | 431.29 | 232 / 245 | 17% | 0.50 | 84 / 502 |
adipose | 100% | 1017.73 | 1204 / 1204 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 12.43 | 29 / 29 |
spleen | 100% | 1954.91 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 2.91 | 1 / 1 |
peripheral blood | 100% | 1775.26 | 926 / 929 | 0% | 0 | 0 / 0 |
ovary | 13% | 37.03 | 24 / 180 | 84% | 6.00 | 363 / 430 |
heart | 86% | 247.99 | 738 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 84% | 5.89 | 38 / 45 |
adrenal gland | 60% | 139.29 | 155 / 258 | 3% | 0.10 | 6 / 230 |
blood vessel | 61% | 231.61 | 811 / 1335 | 0% | 0 | 0 / 0 |
brain | 5% | 11.43 | 140 / 2642 | 29% | 0.97 | 205 / 705 |
liver | 18% | 39.29 | 40 / 226 | 15% | 0.96 | 60 / 406 |
eye | 0% | 0 | 0 / 0 | 29% | 1.18 | 23 / 80 |
muscle | 26% | 58.19 | 207 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0043029 | Biological process | T cell homeostasis |
GO_0001914 | Biological process | regulation of T cell mediated cytotoxicity |
GO_0097190 | Biological process | apoptotic signaling pathway |
GO_0070235 | Biological process | regulation of activation-induced cell death of T cells |
GO_0032649 | Biological process | regulation of type II interferon production |
GO_0048535 | Biological process | lymph node development |
GO_0007165 | Biological process | signal transduction |
GO_0060545 | Biological process | positive regulation of necroptotic process |
GO_0051607 | Biological process | defense response to virus |
GO_2001244 | Biological process | positive regulation of intrinsic apoptotic signaling pathway |
GO_0097528 | Biological process | execution phase of necroptosis |
GO_0002819 | Biological process | regulation of adaptive immune response |
GO_0048536 | Biological process | spleen development |
GO_0072593 | Biological process | reactive oxygen species metabolic process |
GO_2000452 | Biological process | regulation of CD8-positive, alpha-beta cytotoxic T cell extravasation |
GO_0033077 | Biological process | T cell differentiation in thymus |
GO_0051092 | Biological process | positive regulation of NF-kappaB transcription factor activity |
GO_0032147 | Biological process | activation of protein kinase activity |
GO_1990000 | Biological process | amyloid fibril formation |
GO_0010922 | Biological process | positive regulation of phosphatase activity |
GO_0042981 | Biological process | regulation of apoptotic process |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0036211 | Biological process | protein modification process |
GO_2000379 | Biological process | positive regulation of reactive oxygen species metabolic process |
GO_0048538 | Biological process | thymus development |
GO_0097300 | Biological process | programmed necrotic cell death |
GO_0097527 | Biological process | necroptotic signaling pathway |
GO_0070266 | Biological process | necroptotic process |
GO_0038061 | Biological process | non-canonical NF-kappaB signal transduction |
GO_0046777 | Biological process | protein autophosphorylation |
GO_0046006 | Biological process | regulation of activated T cell proliferation |
GO_0070301 | Biological process | cellular response to hydrogen peroxide |
GO_0032991 | Cellular component | protein-containing complex |
GO_0005829 | Cellular component | cytosol |
GO_0005737 | Cellular component | cytoplasm |
GO_0005634 | Cellular component | nucleus |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0042802 | Molecular function | identical protein binding |
GO_0004672 | Molecular function | protein kinase activity |
GO_0005524 | Molecular function | ATP binding |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0005515 | Molecular function | protein binding |
Gene name | RIPK3 |
Protein name | Receptor interacting serine/threonine kinase 3 Receptor-interacting serine/threonine-protein kinase 3 (EC 2.7.11.1) (RIP-like protein kinase 3) (Receptor-interacting protein 3) (RIP-3) |
Synonyms | RIP3 |
Description | FUNCTION: Serine/threonine-protein kinase that activates necroptosis and apoptosis, two parallel forms of cell death . Necroptosis, a programmed cell death process in response to death-inducing TNF-alpha family members, is triggered by RIPK3 following activation by ZBP1 . Activated RIPK3 forms a necrosis-inducing complex and mediates phosphorylation of MLKL, promoting MLKL localization to the plasma membrane and execution of programmed necrosis characterized by calcium influx and plasma membrane damage . In addition to TNF-induced necroptosis, necroptosis can also take place in the nucleus in response to orthomyxoviruses infection: following ZBP1 activation, which senses double-stranded Z-RNA structures, nuclear RIPK3 catalyzes phosphorylation and activation of MLKL, promoting disruption of the nuclear envelope and leakage of cellular DNA into the cytosol (By similarity). Also regulates apoptosis: apoptosis depends on RIPK1, FADD and CASP8, and is independent of MLKL and RIPK3 kinase activity (By similarity). Phosphorylates RIPK1: RIPK1 and RIPK3 undergo reciprocal auto- and trans-phosphorylation . In some cell types, also able to restrict viral replication by promoting cell death-independent responses (By similarity). In response to Zika virus infection in neurons, promotes a cell death-independent pathway that restricts viral replication: together with ZBP1, promotes a death-independent transcriptional program that modifies the cellular metabolism via up-regulation expression of the enzyme ACOD1/IRG1 and production of the metabolite itaconate (By similarity). Itaconate inhibits the activity of succinate dehydrogenase, generating a metabolic state in neurons that suppresses replication of viral genomes (By similarity). RIPK3 binds to and enhances the activity of three metabolic enzymes: GLUL, GLUD1, and PYGL . These metabolic enzymes may eventually stimulate the tricarboxylic acid cycle and oxidative phosphorylation, which could result in enhanced ROS production . .; FUNCTION: (Microbial infection) In case of herpes simplex virus 1/HHV-1 infection, forms heteromeric amyloid structures with HHV-1 protein RIR1/ICP6 which may inhibit RIPK3-mediated necroptosis, thereby preventing host cell death pathway and allowing viral evasion. . |
Accessions | Q9Y572 ENST00000646516.2 [Q9Y572-1] ENST00000554756.1 [Q9Y572-3] ENST00000554569.1 H0YJN5 ENST00000643393.1 [Q9Y572-3] ENST00000216274.10 [Q9Y572-1] |